Company registration number= 2977135
Charity registration number: 1049067
Wythenshawe Hospital Transplant Fund
(A company limiied by guarantee)
Annual Report and Financial Statements
for the Year Ended 31 March 2024

Wythenshawe Hospital Transplant Fund
Contents
Reference and Administrative Details
Trustees, Report
2to4
Statement of Trustees, Responsibilities
Independent Examinetrs Report
Statement of Financial Activities
7t08
Balance Sheet
Notes to the Financial Statements
IOto20

Wythenshawe Hospital Transplant Fund
Reference and Administrative Details
Trustees
Dr P Callan
D K Cornwall
N Eadie
S Fowler
E Mather
W Noble
R Venkateswaran
R Wood
MJHill
Secretary
L C Ellis
Charity Registration Number
1049067
Companv Registration Number
2977135
The charity is incorporated in England and Wales.
The Transplant Fund Olfice
Transplant Centre
Wjthenshaii'e H05Pital
Manchester
M23 9LT
Principal orriee
Independent Examiner
Helen Binns FCA
Chartered Accountant
Beever and Struthers
One Expre55
l George Leigh Street
Manche5teT
M5 4DL
Solieitors:
Addleshaw Goddard
One St Petevs Square
Manchester
M2 3DE
Bankers
HSBC Bank plc
I I Stamford New Road
Altrincham
WA14 IBW
W H I￿ land
I I St James's Square
Manchester
M2 6WH
Page I

Wythenshawe Hospital Transplant Fund
Trustees, Report
The trustees, who are directors for the purposes of company law, present the annual report together with the
financial statements and auditors, report of the charitable company for the year ended 31 March 2024.
Trustees and officers
The trustees and officers serving during the year and since the year end were as follows:
Trustees:
Dr P Callan
D K Cornwall
N Eadie
S Fowler
E Mather
W Noble
R Venkateswaran
J Haworth (resigned 6 December 2023)
R Wood
M J Hill (appointed 7 December 2023)
Objectives and activities
Objects and ainLS
In setting our objectives and planning our activities. the Trustees have given careful consideration to the Charity
Commission's general guidance on public benefit.
As detennined by the charity's Memorandum and Articles of Association, the principal activity of the charity is to
support the programme of heart and lung transplantation at Wythensham'e Hospital. Manchester, serving the North
West of England. Whilst the NHS provides substantial funds for the transplant centre there is alwa}'s a demand for
state-of-the-art equipment or money to support pioneering treatments and research which the NHS is unwilling to
fund. The charity plays a vital role by providing funds to accelerate the adoption of new procedures and by funding
research which advances the technolo¥￿ surrounding transplantation. thus enabling the Wjthenshawe Transplant
Centre to remain at the forefront of excellence lor the treatment of cardiac and lung disease.
The charity is in regular contact with Wythenshawe H05Pital and receive5 funding requests from the hospital. The
Board determine5 whether to meet these requests for funding. The charity doe5 not enter into contractual
relationships with suppliers of equipment and service5. It only provide5 the agreed funding. The T￿SleeS, policy is
to approve all major grants prior to commitment of funds. Wilh the exception of minor funding of up to £5,000,
which may be approved by the Chairnian, decisions relating to the allocation of funds are reserved to the Board and
cannot be delegated.
Public benefit
All the activities of the charity are undertaken to further public benefit.
The trustees confirm that they have complied with the requirements of section 17 of the Charities Act 201 I to have
due regard to the public benefit guidance published by the Charity Commission for England and Wales.
Page 2

Wythenshawe Hospital Transplant Fund
Trustees, Report
Aehievements and performanee
Voluntary donations, legacies and other trading activities raised a total of £131,556 (2023= £131,443) grant income
was £10,000 (2023.. £nil) and investment incorne on our investments and cash deposits generated £29,504 (2023=
£24,530). This has allowed the Trustees of the charity to continue the support for requests submitted to it.
Achievements this year have included continuing to purchase Sherpa packs for the more efficient transportation of
donor hearts, financial support for the Transplant Games participants and equipment for patients use on the Jim
Quick Ward. The major refurbishment works M'hich we have planned for the Jim Quick Ward have once again been
put on hold.
Financial review
The results for the year and their impact on the Charity's funds are set out in delail in the Statement of Financial
Activities. Total net income for the year was £73:157 (2023- £94,195) and the year-end net assets amounted to
£1,508,550 (2023- £1,435,393).. including £1,517,936 (2023.. £1,444,152) in cash at the bank or invested in UK
Govemment Stocks: corporate bond funds and Open Ended Investment Companies.
Policy on reserves
The charity's reserve5 are represented by its iTJvestsnents and cash balances. The Trustees have reviewed the
charity's requirements for unrestricted reserves in the litsht of the main risk's to the organisation. In the opinion of the
Trustees, sufficient unrestricted reserves are required 10 meei one year s operaiing cosis in the event of a significant
drop in incoming resources and £50,000 is considered io be adequaie for this purpose. The balance of the
unrestricted reserves are free reserves and are available to be used to fund projects in accordance with the charity's
objects.
At 31 March 2024 the unrestricted reserves were £1,500,152 (2023: £1,422,039}. The trustees consider that the
reserves held at the year end are above target level.
Inveslmcntpolicy and objeclive5
The Trustees are empow'ered to invest and deal w'ith the monies of the charity not immediately required in such a
manner as the charity may from lime to time detennine subject to such conditions and consents imposed or required
by law. Surplus funds are placed on deposit either with the charity's bankers or with W H Ireland Ltd or invested in
UK Government Stocks, corporate bond funds and unit trnsts. Investment returns are governed by the prevailing
interest rates and dividend payments.
Structure) governance and management
Recruilment and appoinlmenl of Irustees
No person tnay be appointed as a Trustee unless approved by all the Trustees. At every general meeting one third of
the Trustees retire by rotation beinu
decided by the length of time in olfice. Subject to the above, University
Hospital of South Manchester NHS Foundation Trust (now Manchester University NHS Foundation Trust) may
appoint one Trustee. Trustees must be aged 18 years or above and not disqualified by reason of Article l O. l of the
charity'5 Articles of Association or in company or charity law. None of the Trustees have aT]y interest in the charity.
Trustees are appointed under the provision of Articles 31 to 33 olthe charity'5 Articles of A550ciation.
Page 3

Wythenshawe Hospital Transplant Fund
Trustees, Report
Induclion and Iroining of Iruslees
All new Trustees receive a fornial briefing from Ihe Chairnian of their duties and responsibilities and receive various
booklets from the Charity Commlssion and Companies House. Truslees are also encouraged to keep themselves
abreast of current and proposed developments in charity regulaiion through access to the Charity Cominission
website and other relevant sources of infonnation.
Major risks and managemenl oflhose risks
The Trustees coniinue to review the charity's activities to identify the major risks to which it is exposed and the
systems established to mitigate risks are periodically reviewed to ensure that they are operating effectively and still
meet the needs of the charity. It has been deterniined that the principal risks and uncertainties are the volatilit), of
investments held by the charity and the continued ability to raise volunlary income. The steps taken by the Trustees
to mitigate these risks as far as practicable are to maintain and regularly review a diversified portfolio of
investments, to maintain sufficient cash reserves and to monitor both investment perfonnance and the level of
voluntary income received at each Board meeting.
Small companies provision statement
This report has been prepared in accordance with the small companies regime under the Companie5 Act 2006.
The annual report was approved by the trustee5 of the charity on 1711212024 and signed on its behalf by:
D K Cornwall
Trustee
Page 4

Wythenshawe Hospital Transplant Fund
Statement of Trustees, Responsibilities
The trustees (who are also the directors of Wythensham'e Hospital Transplant Fund for the purposes of company
law) are responsible for preparing the twstees, report and the financial statements in accordance with applicable law
and United Kingdom Accounting Standards (United Kingdom Generally Accepied Accounting Practice), including
FRS 102 "The Financial Reporting Standard applicable in ihe UK and Republic of Ireland"
Company laTh' requires the trustees to prepare financial statements for each financial year. Under coTnpany law the
trustees must not approve the financial statements unless they are satisfied that they give a t￿e and fair view of the
state of affairs of the charitable company and of the incoming resources and application of resource5, including its
income and expenditure, of the charitable company for that period. In preparing these financial statements, the
trustees are required io:
select suitable accounting policies and apply them consistently-
observe the methods and principles in the Charities SORP;
make judgements and estimates that are reasonable and prudent;
state whether applicable accounting standards. comprising FRS I O? have been followed, subject to any material
departures disclosed and explained in the financial statements- and
prepare the financial sthiements on the going concern basis unless it is inappropriate to presume that the
charithble company will continue in business.
The trustees are responsible for keeping proper accounting records that can disclose M'ith reasoT]able accuracy at any
time the financial position of the charitable company and enable them to ensure that the financial 5tatement5 comply
with the Companies Act 2006. They are also responsible for Safeguarding the assets of the charitable company and
hence for taking reasonable Steps for the prevention and detection of fraud and other irregularities.
The trustees are responsible for the maintenance and integrity of the corporate and financial infomation included on
the charitable company's website. Legislation governing the preparation and dissemination of financial statements
may differ from legislation in other jurisdictions.
Approv
the trustees of the charity on .1711212024 and signed on its behalf by:
D K Cornwall
Trustee
Page 5

Wythenshawe Hospital Transplant Fund
Independent Examiner's Report to the trustees of W)'thenshawe Hospital Transplant Fund
{'the Company,)
I report to the charity trnstees on my examination of the accounts of the Company for the year ended 31 March
2024.
Responsibilities and basis of report
As the charity's trustees of the Company (and also its directors for the purposes of company law) you are
responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ('the
2006 Act,).
Having satisfied myself that the accounts of the Company are not required to be audited under Part 16 of the 2006
Act and are eligible for independent examination, I report in respect of my examination of your charity's accounts as
carried out under section 145 of the Charities Act 2011 {'the ?01 l Act,). In carying out my examination I have
followed the Directions given by the Charity Commission under section 145(5Mb} of the 2011 Act.
Independenl examiner's statement
I have completed my examination. I confTh thal no matters have come to my attention in connection with the
examination giving me cause to believe:
accounting records were not kept in ￿Spect of Wythenshawe Hospital Transplant Fund as required by section
386 of the 2006 Act; or
2. the accounts do not accord with those records; or
3. the accounts do not comply with the accounting requirements of section 396 of the 2006 Act other than any
requirement that the accounts give a 'true and fair view. which is not a matter considered as part of an
independent examination- or
4. the accounts have not been prepared in accordance with the methods and principles of the Statement of
Recommended Practice for accounting and reporting by chariiies [applicable to charities preparing their
accounts in accordance with the Financial Reponing Siandard applicable in the UK and Republic of Ireland
(FRS 102)].
I have no concerns and have come across no other matters in connection with the examination to which attention
should be drawn in this report in order to enable a proper undersLqnding of the accounts to be reached.
M.f.
Helen Binns FCA
Chartered Accountant
Beever and Struthers
One Express
l George Leigh Street
Manchester
M5 4DL
Date..17th December 2024
Page 6

Wythenshawe Hospital Transplant Fund
Statement of Financial Activities for the Year Ended 31 March 2024
(Including Income and Expenditure Account and Statement of Total Recognised Gains and
Losses)
Unrestrieted
funds
Restricted
funds
Total
2024
Note
Ineome and Endowments from:
Donations and legacies
Other trading activities
Investment incotne
77,061
54,495
29,505
10,000
87,061
54,495
29,505
Total income
161.061
10,000
171,061
Expendilure on:
Raising funds
Chariiable activities
(17,940)
(98,2) l}
(17,940)
(113.187)
(14,956)
Total expenditure
Gainsllosses on investment assets
(116.171}
33,223
(14,956)
(131.127)
33,223
Net incomel(expenditure)
78,113
(4,956)
73,157
Net movement in funds
78,113
(4,956)
73,157
Reconciliation of funds
Total funds brought forward
1,422.OJ9
13,354
1,435,393
Total funds carried forward
18
1,500,152
8,398
1,508,550
The notes on pages 10 to 20 fom) an iniegrdl part of these financial slatements.
Page 7

Wythenshawe Hospital Transplant Fund
Statement of Financial Activities for the Year Ended 31 March 2024
(Including Income and Expenditure Account and Statement of Total Recognised Gains and
Losses)
Unrestrieted
funds
Restricted
funds
Total
2023
Note
Ineome and Endowments from:
Donations and legacies
Other trading activities
Investment incotne
101,230
30,213
24,530
101,230
30,213
24,530
Total income
155.973
155,973
Expendilure on:
Raising funds
Chariiable activities
(8.969)
(10,88i}
(8,969)
(14,545)
(3,660)
Total expenditure
Gainsllosses on investment assets
(19,854}
(38,264)
(3,660)
(23,514)
(38,264)
Net incomel(expenditure)
97,855
(3,660)
94,195
Net movement in funds
97,855
(3,660)
94,195
Reconciliation of funds
Total funds brought forward
1,324.184
17,014
1,341,198
Total funds carried forward
18
1,42?,039
13,354
1,4J5,393
All of the charity's activitie5 derive from continuing operdtion5 during the above two periods.
The funds breakdown for 2023 is shown in note 18.
The notes on pages 10 to 20 fom) an iniegrdl part of these financial slatements.
Page 8

Wythenshawe Hospital Transplant Fund
(Registration number: 2977135)
Balance Sheet as at 31 March 2024
2024
2023
Note
Fixed assets
Tangible assets
12
818
Current assets
Stocks
Debtors
13
14
15
16
200
200
178
520,355
923,797
Investtnents
Cash at bank and in hand
553,491
964.445
,518.327
1,444,530
Credilors: Amounts falling due within one year
17
(10,595)
(9,137)
Net eurrent assets
1,507,732
1,4J5,393
Net assets
,508,550
1,435,393
Funds of the charity:
Restricted income funds
Restricted funds
8,398
13,354
Unrestricted income funds
Unrestricted funds
1,500,152
1,422,039
Total funds
18
,508,550
1,435,393
For the financial year ending 31 March 2024 the charity was entitled to exemption from audit under section 477 of
the Companies Act 2006 relating to small companies.
Directors, responsibilities:
The trusteesldirectors have not required the charity to obtain an audit of its accounts for the year in question in
accordance with Section 476- and
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to
accounting records and the prepardtion of accounts.
The financial statements on pages 7 to 20 were approved by the trustees, and authorised for issue on
and sioned
ehalf by:
1711212024
D K Cornw'all
Trustee
The notes on pages 10 to 20 fom) an iniegrdl part of these financial slatements.
Page 9

Wythenshawe Hospital Transplant Fund
Notes to the Financial Statements for the Year Ended 31 March 2024
I Charity stalus
The charity is a private company limited by guarantee. incorporated in England and Wales. and consequently does
not have share capital. Each of the trustees is liable to contribute an amount not exceeding £ I towards the a55et5 of
the charity in the event of liquidation.
The address of its regis(ered office is:
The Transplant Fund Office
Transplant Centre
Wirthenshawe Hospital
Manchester
M23 9LT
2 Accounting policies
Summary of significant accounting policies and key accounting estimates
The principal accounting policies applied in the preparation of these financial statements are set out below. These
policies have been consistently applied to all the years presented. unless othenvise slated.
Statement of eomplianee
The financial statements have been prepared in accordance with Accounting and Reporting by Charities.. Statement
of Recommended Practice (applicable to charities preparing their accounts in accordance with the Financial
Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)) (issued in October 2019) - (Charities
SORP (FRS 102)), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and
the Companies Act 2006.
Basis of preparation
WythenSha￿'e Hospital Transplant Fund tneets the definition of a public benefit entity under FRS 102. Assets and
liabilities are initially recognised at historical cost or transaction value unle55 Otherwise stated in the relevant
accounting policy note5.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Going eoncern
The trustees consider that there are no material uncertainties about the charit) s ability to continue as a going
concern nor any significant areas of uncertainty that affect the carri'ing value of assets held by the charity.
Page 10

Wythenshawe Hospital Transplant Fund
Notes to the Financial Statements for the Year Ended 31 March 2024
Critical accounting judgements and key sources of estimation uncert2inty
The preparation of the financial statements in conforniity with FRS 102 requires the use of certain critical
accounting estimates. It can also require the Trustees to exercise their judgement in the process of applying the
charity's accounting policies. The charity is not considered to have any critical accounting estimates or judgements
at this time.
Income and endoiTrment5
All income is recognised once the charity has entitlement to the income, it is probable that the income will be
received and the amount of the income receivable can be measured reliably.
Donations and legacies
Donations are recognised when the charity has been notified in writing of both the amount and settlement date. In
the event that a donation 15 subject to conditions that require a level of performance by the charity before the charity
Is entitled to the funds, the income is deferred and not recognised until either those conditions are fully met, or the
fulfilment of those condition5 15 wholly within the control of the charity and it 15 probable that these conditions will
be fulfilled in the reporting period.
Legacy gifts are recognised on a case by case basi5 folloiving the grant of probate when the administrator/executor
for ihe estate has communicaied in writing boih ihe amount and settlement date. In the event that the gift is in the
forn) of an asset other ihan cash or a financial asset traded on a recognised stock exchange, recognition is subject to
the value of the gift being reliably measurable with a detsree of reasonable accuracy and the title to the asset having
been transferred to the charity.
Grants receivable
Grants are recognised when the charity has an entitlemeni to the funds and any conditions linked to the grants have
been met. Where perfomiance condilions are attached to ihe grant and are yet to be met, the income is recognised as
a liability and included on the balance sheet as deferred income to be released.
Investmenl income
Dividends are recognised once the dividend has been declared and notification has been received of the dividend
due.
Expenditure
All expenditure is recognised once there is a legal or constructive obligation to that expenditure, it is probable
settlement is required and the amount can be measured reliablv. All costs are allocated to the appllcable expenditure
heading that aggregate similar costs (o that calegory. Where costs cannoi be directly attributed to particular headii)gs
they have been allocated on a basis consistent with the use of resources, with centrdl staff costs allocated on the
basis of time spent, and deprecialion charges allocated on the portion of the asset's use. Other support costs are
allocated based on the spread of staff cosls.
Raisingfunds
These are costs incurred in attracting voluntary income, the management of inveslments and those incurred in
trading activities that raise funds.
Page I

Wythenshawe Hospital Transplant Fund
Notes to the Financial Statements for the Year Ended 31 March 2024
Charilable activilies
Chariiable expenditure comprises those costs incurred by the charity in Ihe delivery of lis activlties and services for
its beneficiaries. It includes both costs that can be allocated directly to such activities and those costs of an indirect
nature necessary to support them.
Taxation
The charity is considered to pass the tests set out in Paragraph I Schedule 6 of the Finance Act 201 O and therefore it
meets the definition of a charitable company for UK corporation tax purposes. Accordingly, the charity is potentially
exempt from taxation in respect of income or capital gains received ￿'1th1n categories covered by Chapter 3 Part I I
of the Corporation Tax Act 201 O or Section 256 of the Taxation of Chargeable Gains Act 1992, to the extent that
such income or gains are applied exclusively to charitable purposes.
Tangible fixed assets
Individual fixed assets costing £0.00 or more are initially recorded at cost, less any subsequent accumulated
depreciation and subsequent accumulated impairnient losse5.
Depreciation and amortisation
Depreciation is provided on tangible fixed assets so as to write off the cost or valuation, less any estimated residual
value, over their expected useful economic life as follows-
Asset class
Computer equipment
Depreeiation method and rate
?O/o Straight line
Current a55et investments
Current asset investments are included at the lower of cosi and net ￿a]isable value / market value.
Stock
Stock is valued at ihe lower of cost and esiimated selling price less costs to complete and sell, after due regard for
obsolete and slow moving stocks. Cosi is deiemiined using the first-in, first-oui (FIFO).
Trade debtors
Trade debtors are amounts due from customers for merchandise sold or services perfonned in the ordinary course of
business.
Trade debtors are recognised iniliall). at the trdnsaction price. They are subsequently measured at amortised cost
using the effective interest method: less provision for impainnent. A provision for the impairnient of trade debtors is
established when there is objective evidence that the charity will not be able to collect all amounts due according to
the original tenns of the receivables.
Cash and eash equivalents
Cash and cash equivalents comprise cash on hand and call deposits: and other short-terrn highly liquid investments
that are readily convertible to a knO￿.n amount of cash and are subject to an insignificant risk of change in value.
Page 12

Wythenshawe Hospital Transplant Fund
Notes to the Financial Statements for the Year Ended 31 March 2024
Fund strueture
Unrestricted income funds are general funds that are available for use at the trustees discretion in furtherance of the
objectives of the charity.
Restricted income funds are those donated for use in a particular area or for specific purposes, the use of which is
restricted to that area or purpose.
Financial inslruments
Classificlllion
Financial assets and fLnancial liabilities are recognised when the charity becomes a party to the contractual
provisions of the instrument.
Financial liabilities and equity instruments are classifled according to the substance of the contractual arrangements
entered into. An equity instrument 15 any contract that evidences a residual interest in the assets of the charity after
deducting all of its liabilities.
Recognition and measuremenl
All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for
those financial assets classified as at lair value thTOU(
.h profit OT loss, which are initially measured at fair value
(which is nornially the transaction price excluding transaction costs). unless the arranuemeT]t constitutes a financing
transaction. If an arranuement constitutes a financinu travjsaction. the financial asset or fLnancial liability is measured
at the present value of the future pa)Tnents discounted at a market rate of interest for a similar debt instrument.
Financial assets and liabilities are only offset in the statement of financial position when. and only when there exists
a legally enforceable right to set off the recognised amounts and the charity intends either to settle on a net basis, or
to realise the asset and seitle the liability simultaneously.
Financial assets are derecognised when and only when a) the contractual rights to the cash floitys from the financial
asset expire or are settled. b) the charity transfers to anoiher party substhntially all of the risks and rewards of
ownership of the financial asset, or c) the chariry, despite having relained some, bui not all, significant risks and
rewards of ownership. has transferred control of the asset lo another party.
Financial liabilities are derecognised only when the obligation specified in the contract is discharged: cancelled or
expires.
Page 13

Wythenshawe Hospital Transplant Fund
Notes to the Financial Statements for the Year Ended 31 March 2024
3 Income from donations and legacies
Unrestrieted
funds
General
Restricted
funds
Total
2024
Donations and legacies.
Donations from companies, trusts and similar proceeds
Donations from individuals
Legacies
In memoriam
Grants, including capital grants.
Grants from companies
2,465
52,013
5,219
17,364
2,465
52,013
5,219
17,364
10,000
10,000
77.061
10,000
87,061
Unrestricted
funds
General
Total
2023
Donations and legacies;
Donations from individuals
Legacies
In memoriam
43,627
35,226
22,377
43,627
35,226
22,377
101.230
101,230
4 Income from other trading activitie5
Unrestrieted
funds
General
Total
2024
Total
2023
Trading income;
Income from sales of n]erchandi5e
Fundraising events
972
53,523
972
53,523
1,949
28,264
54,495
54,495
30,213
Page 14

Wythenshawe Hospital Transplant Fund
Notes to the Financial Statements for the Year Ended 31 March 2024
5 Inveslment income
Unrestrieted
funds
General
Total
2024
Total
2023
Interest receivable and similar income;
Interest receivable on bank deposits
Oiher investment income
13,185
16,320
13,185
2,459
22,071
29.505
29,505
24,530
6 Expenditure on raising funds
a) Costs of trading aetivities
Unreslrieted
runds
General
Total
2024
Total
2023
Fundraising trading costs;
Fundraising
Costs of goods sold
7.719
2.622
7,719
2,622
2,492
10,341
10,341
2,492
Page 15

Wythenshawe Hospital Transplant Fund
Notes to the Financial Statements for the Year Ended 31 March 2024
b) Inveslment management costs
Unrestrieted
funds
General
Total
2024
Total
2023
Interest payable;
Other interest payable
Finance charges;
Bank charges
Other investment management cosls;
Amounts payable to inves(ment managers
64
679
679
227
6.856
6,856
6,250
7.599
7,599
6,477
7 Expenditure on charitable activities
Unrestrieted
funds
General
Restricted
funds
Total
2024
Medical supplies / equipment
Other charitable donation5
Administration and other costs
Staff costs
42,122
24,407
19,655
12,047
3,666
11,008
282
45,788
35,415
19,937
12,047
14,956
113,187
Unreslrieted
funds
General
Restricted
funds
Total
2023
Medical supplies / equipment
Refurbishment costs
Other charitable donations
Administration and other costs
Staff costs
31.217
(89.719)
33.998
13.020
31,217
(89,719)
37,658
13,020
3,660
10,885
3,660
14,545
Page 16

Wythenshawe Hospital Transplant Fund
Notes to the Financial Statements for the Year Ended 31 March 2024
8 Net incomingloutgoing resources
Net incoming resources for the year include:
2024
2023
Depreciation of fixed assets
Finance charges payable
Independent Examiners Fee
205
679
2.500
227
2,340
9 Trustees remuneration and expen5e5
No trustees, nor any persons connected with them. have received any remuneration from the charity during the year.
No trustees have received any reimbursed expenses or any other benefits from the charity during the year.
10 Staff costs
The aggregate payroll costs were as follows:
2024
2023
Staff costs during the year were:
Wages and salaries
Pension costs
11,468
579
21,074
1,295
12,047
22,369
The monthly average number of persons (including senior management / leadership team} employed by the charity
during the year expressed as full time equivalents was as follows:
2024
2023
Administrative Staff
No employee received emoluments of more than £60.000 during the year.
I l Taxatio
The charity is a registered charity and is therefore exempt from taxation.
Page 17

Wythenshawe Hospital Transplant Fund
Notes to the Financial Statements for the Year Ended 31 March 2024
12 Tangible fixed assets
Computer
equipment
Total
Cost
Additions
1,023
1,023
At 31 March 2024
1,023
1,023
Depreciation
Charge for the year
205
205
At 31 March 2024
205
205
Net book value
At 31 March 2024
818
818
13 Stock
2024
2023
Stocks
200
200
14 Debtors
2024
2023
Prepayments
Other debtors
177
178
IS Current asset investments
2024
2023
Listed other shares
553,491
520,J55
16 Cash and cash equivalents
2024
2023
Cash at bank
964,445
923.797
Page 18

Wythenshawe Hospital Transplant Fund
Notes to the Financial Statements for the Year Ended 31 March 2024
17 Creditors: amounts falling due within one vear
2024
2023
Other taxation and social security
Accruals
628
9,967
545
8,592
10,595
18 Funds
Other
recognised
gains/(losses)
Balanee at
31 March
2024
Balance at I
April 2023
Incoming
resources
Resources
expended
Unrestricted funds
General
1,422,0)9
161,061
(116,171)
33,223
1,500,152
Restricted funds
10.000
(14,956)
8,398
Total funds
1,435,393
171.061
(131.127)
33,223
1,508,550
Other
recognised
gains/(losses)
Balance at
31 March
2023
Balance at I
April 2022
Incoming
resource5
Resources
expended
Unrestricted funds
General
1.324.184
155.973
(19,854)
(38,264)
1,422,039
Restricted funds
17,014
{3,660)
13,354
Total funds
1.341,198
155.973
(23,514)
(J8,264)
1,435,393
The specific purposes for which the funds are to be applied are as follows:
The restricted income funds comprise amounts given by donors who indicate thai their donations are to be spent on
specific iiems to be used, or projecis io be carried out. ai Wythenshaii¥e Hospithl to further the objects of the charity.
The balance at the year end can be split beiween equipment for hearts £424 {2023'. £4,090), expenditure for the
bungalows £7.641 (2023.. £7,92J), educalional grant £3J2 (2023: £1.340)
Page 19

Wythenshawe Hospital Transplant Fund
Notes to the Financial Statements for the Year Ended 31 March 2024
19 Analysis of net assets behveen funds
Unrestrieted
funds
General
Total funds at
31 March
2024
Restricted
funds
Tangible fixed assets
Current assets
Current liabilities
818
1,509,929
(10,595)
818
1,518,327
(10,595)
8,398
Total net assets
1,500.152
8,398
1,508,550
Unreslrieted
funds
General
Total funds at
31 March
2023
Restricted
funds
Current assets
Current liabilities
1,4Jl,176
(9,137}
13,354
1,444,530
(9,137)
Total net assets
1,422,039
13,354
1,435,393
20 Related party transactions
There were no related party transactions in the year.
Page 20